Home | News & Events | IDEA News | Dementia drug research aided by $100 million venture capital fund

Dementia drug research aided by $100 million venture capital fund

The world's first venture capital fund dedicated to finding new ways to prevent and treat dementia has raised more than $100 million with the backing of the British government and several of the world's leading drugmakers.

The global Dementia Discovery Fund is unique in focusing on a single difficult to treat disorder and in bringing together industry and government.

Read more on the Reuters website.